Atelvia and Dizziness - a phase IV clinical study of FDA data

Summary:

Dizziness is reported as a side effect among people who take Atelvia (risedronate sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Humira, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Dizziness when taking Atelvia. It is created by eHealthMe based on reports of 587 people who have side effects when taking Atelvia from the FDA, and is updated regularly.

What is Atelvia?

Atelvia has active ingredients of risedronate sodium. It is often used in osteoporosis. eHealthMe is studying from 611 Atelvia users. Check the latest studies of Atelvia.

What is Dizziness?

Dizziness is found to be associated with 3,568 drugs and 5,710 conditions by eHealthMe. Check the latest studies of Dizziness.

On Jul, 14, 2026

587 people reported to have side effects when taking Atelvia.
Among them, 21 people (3.58%) have Dizziness.

Among these 21 people:

How long have people been on Atelvia when they have Dizziness? *

What is the gender of people who have Dizziness when taking Atelvia? *

female: 90 %
male: 10 %

What is the age of people who have Dizziness when taking Atelvia? *

What are other drugs people take besides Atelvia? *

What are other side effects people have besides Dizziness? *

Chest Pain: 7 people, 33.33%
Weakness: 7 people, 33.33%
Headache (pain in head): 6 people, 28.57%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 23.81%
Abdominal Pain Upper: 5 people, 23.81%
Back Pain: 4 people, 19.05%
High Blood Pressure: 4 people, 19.05%
Nausea (feeling of having an urge to vomit): 4 people, 19.05%
Flatulence (flatus expelled through the anus): 4 people, 19.05%
Muscle Aches (muscle pain): 4 people, 19.05%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 19.05%
Depression: 3 people, 14.29%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 14.29%
High Blood Pressure: 3 people, 14.29%
Osteopenia (a condition where bone mineral density is lower than normal): 3 people, 14.29%
Pain: 3 people, 14.29%
High Blood Cholesterol: 3 people, 14.29%
Bone Disorder: 3 people, 14.29%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 9.52%
Interstitial Lung Disease: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Atelvia and have Dizziness?

- Check whether Dizziness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atelvia:

Atelvia (611 reports)

Dizziness treatments and more:

Dizziness (613,960 reports)

Browse all side effects of Atelvia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dizziness:

Dizziness (3,568 drugs)

Browse all the conditions that are associated with Dizziness:

Dizziness (5,710 conditions)

Related publications that referenced our studies

Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on risedronate sodium (the active ingredients of Atelvia) and Atelvia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.